JPRN-UMIN000032147
Completed
Phase 1
A clinical study on the safety of immune-cell therapy combined with standard therapy for high-grade glioma - A clinical study on the safety of immune-cell therapy combined with standard therapy for high-grade glioma
Juntendo University Faculty of Medicine0 sites5 target enrollmentApril 9, 2018
Conditionsglioma
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- glioma
- Sponsor
- Juntendo University Faculty of Medicine
- Enrollment
- 5
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Be apparent from the clinical manifestation of pulmonary fibrosis or interstitial pneumonia 2\)Have a history of a serious drug allergy 3\)Have a positive result of HIV or HTLV\-1 antibody test 4\)Have a serious cardiac disorder 5\)Have an active autoimmune disorder 6\)Have a cancer other than glioma 7\)Have an infectious disorder that is difficult to control 8\)Be a female who is pregnant
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
evaluate the safety and immunomodulatory efficacy of Byolic CC supplementImmunomodulatory effect on healthy volunteers.IRCT20240304061158N4Behpad Teb Iranian90
Unknown
Phase 3
A clinical trial to study immunogenicity and safety of Purified Chick Embryo Cell Culture Rabies Vaccine administered intradermallyHealth Condition 1: Z23- Encounter for immunizationCTRI/2010/091/000509Cadila Healthcare Ltd36
Completed
Phase 4
Protection and Safety of rabies vaccine when administered intradermallyCTRI/2012/06/002720I70
Active, not recruiting
Phase 1
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers when Administered Concomitantly with Routine Pediatric Vaccines in the UK.EUCTR2017-004520-30-GBSanofi Pasteur700
Active, not recruiting
Phase 1
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine when co-administered with Routine Pediatric Vaccines in Healthy Infants and Toddlers in EuropeHealthy volunteers (active immunization against invasive meningogoccal disease (IMD) caused by Meningococcal serogroups A, C, Y or W)MedDRA version: 20.0Level: PTClassification code 10027274Term: Meningococcal infectionSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2017-004731-36-ITSanofi Pasteur Inc.1,540